News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
93 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57663)
2021 (58720)
2022 (53928)
2023 (42564)
2024 (37441)
2025 (33091)
2026 (16515)
Month
January (2433)
February (2866)
March (3029)
April (3115)
May (3356)
June (1716)
Day
1 (213)
2 (187)
3 (160)
4 (139)
5 (74)
7 (52)
8 (139)
9 (151)
10 (114)
11 (133)
12 (58)
14 (27)
15 (145)
16 (93)
17 (31)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
Day
1
2
3
4
5
7
8
9
10
11
12
14
15
16
17
Rare diseases
6 times when drug development got personal
While biopharma’s overarching mission is to develop innovative medicines to improve patient outcomes, for these six people, the motivation came from much closer to home.
June 16, 2026
·
9 min read
·
Tristan Manalac
Rare diseases
Intellia’s gene editor ‘keeps pace’ with Ionis in hereditary angioedema
With a one-time dosing profile, Intellia Therapeutics’ gene editing asset could be “paradigm-shifting” for hereditary angioedema, according to Jefferies. The biotech anticipates market approval next year.
June 16, 2026
·
2 min read
·
Tristan Manalac
Depression
Alto’s depression candidate bolstered by independent study showing mood benefits
Alto Neuroscience is advancing a depression drug based on the dopamine agonist pramipexole, which an independent study has found to help boost feelings of pleasure in patients with mood disorders.
June 16, 2026
·
2 min read
·
Tristan Manalac
Rare diseases
Mirum, Incyte bolster case for approval in rare bone disease despite mid-stage miss
While falling short of statistical significance, Incyte and Mirum Pharmaceuticals’ ALK2 inhibitor showed a “clear benefit” in reducing abnormal bone formation in a Phase 2 study of fibrodysplasia ossificans progressiva.
June 16, 2026
·
2 min read
·
Tristan Manalac
Layoff Tracker
Neumora, enGene cut staff in cost-saving initiatives
Follow along as
BioSpace
tracks job cuts and restructuring initiatives.
June 16, 2026
·
61 min read
·
BioSpace Editorial Staff
Vaccines
FDA, Moderna appear aligned on mRNA flu shot heading into adcomm
The Vaccines and Related Biological Products Advisory Committee will meet June 18 to discuss Moderna’s seasonal flu vaccine mRNA-1010 after the FDA initially refused to accept the application in February.
June 16, 2026
·
3 min read
·
Annalee Armstrong
Press Releases
PURE Bioscience Reports Fiscal Third Quarter 2026 Financial Results
June 16, 2026
·
9 min read
Press Releases
Verastem Oncology to Host Investor Conference Call and Report Updated Data and Progress Across VS-7375 Oral KRAS G12D (ON/OFF) Inhibitor TARGET-D Clinical Program
June 16, 2026
·
3 min read
Press Releases
C-Path Reaffirms Commitment to Advancing Regulatory Science for Disease-Modifying Therapies in Type 1 Diabetes
June 16, 2026
·
5 min read
Press Releases
Saptalis Pharmaceuticals Launches Cyclosporine Ophthalmic Emulsion 0.05% and Expands Product Portfolio
June 16, 2026
·
2 min read
1 of 10
Next
